Parafluorofentanil

Parafluorofentanyl is an extremely potent synthetic opioid and analogue of fentanyl, originally developed by Janssen Pharmaceutica during the 1960s. It is classified as a depressant with significant habit-forming potential. The substance remains rare, and relatively little is known about its pharmacological profile or safety margins. Due to its exceptional potency, it should be handled with extreme caution, and combining it with other depressants is strongly discouraged due to the heightened risk of fatal respiratory depression.

Also known as: Pff, 4-fluorofentanyl, Parafluorofentanyl, p-fluorofentanyl

Classification

Chemical: Anilidopiperidine
Chemical: Opioid
Psychoactive: Depressant
Tag: Fentanyl analogue
Tag: Habit-Forming
Tag: Sedative
Tag: Tentative

Effects

Respiratory Depression
Itchiness
Nausea
Sedation
Motor Impairment
Constipation
Reduced Anxiety
Euphoria
Anxiety Suppression
Dizziness
Sadness
Cognitive Euphoria
Dulled Perception
Open Eye Visuals
Sound Dampening

Routes of Administration

Insufflated

Dosage

Heavy: 65 ug
Light: 10 – 25 µg
Common: 25 – 40 µg
Strong: 40 – 65 µg
Threshold: 10 ug

Duration

No data available for this section yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu